ABBOTT INDIA
Back to Balance Sheet
|
ABBOTT INDIA Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹114 Cr | ₹106 Cr | ₹97 Cr | ₹87 Cr | ₹121 Cr |
What is the latest Contingent Liabilities ratio of ABBOTT INDIA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹114 Cr |
| Mar2025 | ₹106 Cr |
| Mar2024 | ₹97 Cr |
| Mar2023 | ₹87 Cr |
| Mar2022 | ₹121 Cr |
How is Contingent Liabilities of ABBOTT INDIA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹114 Cr | 7.46 | |
| Mar2025 | ₹106 Cr | 10.00 | |
| Mar2024 | ₹97 Cr | 10.44 | |
| Mar2023 | ₹87 Cr | -28.00 | |
| Mar2022 | ₹121 Cr | - | |
Compare Contingent Liabilities of peers of ABBOTT INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ABBOTT INDIA | ₹55,323.9 Cr | -3.6% | -9.7% | -20% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | -1.2% | -2.2% | 15.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹227,958.0 Cr | 1% | 16.3% | 39.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,990.0 Cr | 3.2% | -0.8% | 38.6% | Stock Analytics | |
| CIPLA | ₹116,141.0 Cr | -0.9% | 1.6% | -9.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,604.4 Cr | -1.7% | -0.1% | -6.5% | Stock Analytics | |
ABBOTT INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ABBOTT INDIA | -3.6% |
-9.7% |
-20% |
| SENSEX | -0.7% |
0.1% |
-3.4% |
You may also like the below Video Courses